Subscribe
Home
Issues
2026
February 2026 - Vol 19 No 1
2025
November 2025 - Vol 18 No 4
August 2025 - Vol 18 No 3
May 2025 - Vol 18 No 2
February 2025 - Vol 18 No 1
2024
November 2024 - Vol 17 No 4
September 2024 - Vol 17 No 3
May 2024 - Vol 17 No 2
February 2024 - Vol 17 No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
Categories
Conference Correspondent
ASCO 2025 - Small Cell Lung Cancer
ONS 2025 - Endometrial Cancer
Web Exclusives
Case-Based Exchanges
Evolving Landscapes in Multiple Myeloma
OFS Summit
Drug Updates
Videos
Interview with the Innovators
Rapid Reactions
Best Practices in Breast Cancer Therapy | OFS
Master Class Series
Ask the Experts
Advanced Endometrial Cancer Education
Resources
Quick Quiz
Articles
Articles
Monitoring for CHF Advised for Breast Cancer Patients Treated with Bevacizumab
TON - Daily
Patients treated with bevacizumab for metastatic breast cancer (MBC) should be monitored closely for cardiotoxicity, according to a new meta-analysis, which showed an increased risk of congestive heart failure (CHF) in women treated with the vascular endothelial growth factor inhibitor compared with controls.
Read More ›
New Evidence of Beneficial Effects of Exercise for Cancer Patients, Survivors
TON - Daily
Clinicians now have more evidence to support exercise recommendations for cancer patients and survivors.
A new study found that regular exercise—even 15 minutes per day—prolongs survival in men with prostate cancer. Other new research has shown that exercise reduces cancer-related fatigue among adult cancer survivors.
Read More ›
Tablet splitting a potentially dangerous practice, new study indicates
TON - Daily
Tablet splitting, a common practice in healthcare settings, results in wide dose deviations, which could have serious clinical consequences for tablets that have a narrow margin between therapeutic and toxic doses, a new study indicates.
The study, published in the January issue of the
Journal of Advanced Nursing
, showed that nearly a third of the split fragments deviated from recommended dosages by 15% or more.
Read More ›
Neurocognitive Problems Linked to Use of Dexamethasone in ALL Survivors
By
Debra Wood
In the News
Web Exclusives
Adult survivors of childhood acute lymphoblastic leukemia (ALL) treated with dexamethasone may have greater risk for neurocognitive impairment and poor emotional regulation than patients treated with prednisone, and they exhibited symptoms of physical stress.
Read More ›
DVT Prophylaxis Underused for Cancer Patients
By
Debra Wood
In the News
Web Exclusives
Almost half of the cancer patients in a recent study did not receive any thromboprophylaxis during hospitalization, even though cancer and its treatment increases the risk for deep-vein thrombosis (DVT) and pulmonary embolism (PE) and three professional organizations—the American College of Chest Physicians, the American Society of Clinical Oncology, and the National Comprehensive Cancer Network—have issued guidelines recommending DVT prophylaxis.
Read More ›
Weightlifting Cuts Lymphedema Risk in Breast Cancer Patients
Web Exclusives
SAN ANTONIO—Weightlifting can significantly reduce the likelihood that breast cancer patients will develop lymphedema after they complete treatment, according to results of the Physical Activity and Lymphedema trial reported at the 33rd annual San Antonio Breast Cancer Symposium.
Read More ›
Base Prostate Cancer Treatment on Risk, Life Expectancy Not Age, Researchers Say
TON - Daily
Clinicians should make decisions about prostate cancer treatment based on disease risk and life expectancy rather than chronologic age, according to University of California, San Francisco, researchers, who found that older men are more likely to have high-risk disease at diagnosis and less likely to receive potentially curative local therapy.
Read More ›
Nurse Counseling Improved Patients’ Adherence to TKIs
By
Debra Wood
TON - February 2011 Vol 4, No 1
ORLANDO—A study of physicians from five countries found that nurses and hematologists counseling patients with chronic myeloid leukemia about the importance of adherence to prescribed tyrosine kinase inhibitors (TKIs) or having an established adherence protocol, such as medication diaries, pill organizers, or informational calendars, was associated with improved adherence, and those patients who took the drugs as prescribed had significantly better therapeutic milestones.
Read More ›
Vitamin Use Found to Be Beneficial in Women with Breast Cancer
TON - Daily
Two new studies suggest that use of vitamin supplements may reduce the risk of disease recurrence and mortality in women with breast cancer.
These studies contrast with some previous studies, which suggested that vitamin supplements, particularly antioxidants, may reduce the effectiveness of radiotherapy or chemotherapy.
Read More ›
Adding Peginterferon alfa-2a Boosts Molecular Response in CML
TON - Daily
More patients with chronic myeloid leukemia (CML) in chronic phase achieve molecular response when peginterferon alfa-2a is added to imatinib therapy, but toxic side effects make completing treatment difficult for many, according to analysis of SPIRIT trial data (
N Engl J Med
. 2010;363:2511-2521). The researchers concluded that this increase in molecular responses could translate into better survival.
Read More ›
Page 353 of 376
350
351
352
353
354
355
356
View the Latest Issue of TON
Read Issue
Home
Issues
2026
February 2026 - Vol 19 No 1
2025
November 2025 - Vol 18 No 4
August 2025 - Vol 18 No 3
May 2025 - Vol 18 No 2
February 2025 - Vol 18 No 1
2024
November 2024 - Vol 17 No 4
September 2024 - Vol 17 No 3
May 2024 - Vol 17 No 2
February 2024 - Vol 17 No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
Categories
Conference Correspondent
ASCO 2025 - Small Cell Lung Cancer
ONS 2025 - Endometrial Cancer
Web Exclusives
Case-Based Exchanges
Evolving Landscapes in Multiple Myeloma
OFS Summit
Drug Updates
Videos
Interview with the Innovators
Rapid Reactions
Best Practices in Breast Cancer Therapy | OFS
Master Class Series
Ask the Experts
Advanced Endometrial Cancer Education
Resources
Quick Quiz
Subscribe Today!
To sign up for our newsletter or print publications, please enter your contact information below.
I'd like to receive:
TON
Print Edition
TON
Weekly e‑Newsletter
-- Please Select --
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, the Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, the former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Vietnam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
I have reviewed and consent to the terms of
TON
's
Privacy Policy
, and
TON
has my permission to retain my information in its database, and to forward pertinent communications to me.
START YOUR SUBSCRIPTION